Cost-effectiveness analysis of alternative colorectal cancer screening strategies in high-risk individuals
Why not simply treat large adenomas of the rectum and ileal pouch after colectomy in familial adenomatous polyposis?
The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis
Cambodian Association of Gastrointestinal Endoscopy - Prof Jean-Christophe Saurin will be giving the lecture on the 4th Virtual Scientific meeting next Saturday! ⏰5th June 2021 ⏰1:00-4:00pm (GMT+7) ⏰Registration is now open: https://us02web.zoom.us ...
![PDF) Why should we systematically specify the clinical relevance of images observed at capsule endoscopy? PDF) Why should we systematically specify the clinical relevance of images observed at capsule endoscopy?](https://i1.rgstatic.net/publication/272957620_Why_should_we_systematically_specify_the_clinical_relevance_of_images_observed_at_capsule_endoscopy/links/55a54e4208ae81aec9134baa/largepreview.png)
PDF) Why should we systematically specify the clinical relevance of images observed at capsule endoscopy?
World Gastroenterology Organisation - WGO continues to celebrate the 20th anniversary of the Train the Trainers program! In the latest issue of e-WGN, Profs. James Toouli, Jean-Christophe Saurin, and Kelly Burak provide
![Performance measures for small-bowel endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative – European Society of Gastrointestinal Endoscopy (ESGE) Performance measures for small-bowel endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative – European Society of Gastrointestinal Endoscopy (ESGE)](https://www.esge.com/site19/wp-content/uploads/2019/05/2019_a_0889_9586_xl.jpg)
Performance measures for small-bowel endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative – European Society of Gastrointestinal Endoscopy (ESGE)
COLON CAPSULE ENDOSCOPY VERSUS COLONOSCOPY IN PATIENTS AT AVERAGE OR INCREASED RISK OF COLORECTAL CANCER
![PDF) Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output | David Ternant - Academia.edu PDF) Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output | David Ternant - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/44408936/mini_magick20190214-25847-eqzw6h.png?1550186307)